HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Cabaletta Bio (NASDAQ:CABA) and maintained a $30 price target, as stated by analyst Douglas Tsao.
May 16, 2024 | 11:54 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Cabaletta Bio and maintained a $30 price target, indicating continued confidence in the company's potential.
The reiteration of a Buy rating and maintenance of a $30 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100